Program overview: Big Data and AI: Can Medicine Do the Doable?

- presentation titles are partially preliminary-

Print version of the program




9:00 - 9:50

Welcome & Intro to DigiMed Bayern & Keynote


Welcome at the Gene CenterProf. Dr. Karl-Peter Hopfner, Director Gene Center Munich


Welcome & Philosophy of DigiMed

Prof. Dr. Heribert Schunkert, Clinical Director, German Heart Centre Munich


Welcome Video Message

Klaus Holetschek, State Minister, Bavarian Minister of Health and Care




Lisbeth Nielsen, Director General, Danish Health Data Authority


Session A:

P4 Medicine examples from DigiMed Bayern


Prof. Dr. Heribert Schunkert, German Heart Centre Munich


Personalised medicine in coronary artery disease is sustainably improved by combining clinical and OMICs data

Dr. Moritz von Scheidt, German Heart Centre Munich


Preventive: Early diagnosis and treatment of children with Familial Hypercholesterolemia, the VRONI-study

Dr. Veronika Sanin, German Heart Centre Munich


Predictive: Epidemiological studies enhanced with molecular phenotypes

Prof. Dr. Annette Peters, Director of the Institute of Epidemiology, Helmholtz Zentrum Munich and and Principal Investigator, German National Cohort (NAKO)


Participatory: HerzFit: Generation of a Health App

Dr. Fabian Starnecker, German Heart Centre Munich & Lara Marie Reimer, Technical University of Munich


Heart(s) of the Matter: P4-Medicine from the Perspective of Ethics

Prof. Dr. Reiner Anselm & Dr. Therese Feiler, Ludwig-Maximilians-University, Institut Technik-Theologie-Naturwissenschaften


 Lunch & Networking



Session B:

Infrastructure & Pilot Projects


Dr. Jens Wiehler, BioM Biotech Cluster Development GmbH


Bavarian Cloud for Health Research - a collaborative infrastructure for biomedicine

Dr. Christian Mertes, Workflow coordinator German Human Genome-Phenome Archive, Munich Data Science Institute, Technical University of Munich


Enabling health data for primary and secondary use in Bavaria and in GAIA-X: Team-X project

Prof. Dr. Björn Eskofier, Friedrich-Alexander-University Erlangen-Nürnberg


Secondary data use supported by national infrastructure

Stefan Höcherl, Director Strategy and Standards, gematik GmbH


Bavarian State: Our vision of data driven health, care and R&D

Dr. Thomas Huber, Head of Department 1, Bavarian State Ministry of Health and Care


 Coffee Break



Session C:

International Benchmarking


Prof. Dr. Horst Domdey, BioM Biotech Cluster Development GmbH


AWS Healthcare: Our view on the German healthcare market and secondary data use in international comparison

Joanna Wardzinski, Health Tech Lead & Operations, International, AWS Healthcare


The Finnish pathway towards the legislative framework for secondary use of social and health data

Dr. Päivi Sillanaukee, Ambassador for Health and Wellbeing, Ministry for Foreign Affairs of Finland


Secondary use of patient data from the perspective of the research-based pharmaceutical industry


Dr. Henning Düwert, Senior Counsel Pharmaceutical Law, Verband Forschender Arzneimittelhersteller e.V.


Overall discussion with audience & closing remarks

All, Prof. Dr. Horst Domdey and Prof. Dr. Heribert Schunkert


 Networking, drinks & fingerfood